Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Botulinum Toxin Injection in the Tennis Elbow Treatment (TBA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00437762
Recruitment Status : Completed
First Posted : February 21, 2007
Last Update Posted : February 28, 2013
Sponsor:
Collaborator:
Ipsen
Information provided by (Responsible Party):
University Hospital, Bordeaux

Brief Summary:
Some studies valued the effectiveness of botulinum toxin. Results are contradictory and we need more studies. The purpose of the study is to compare the effectiveness of botulinum toxin injection with placebo in the treatment of tennis elbow unrelieved by usual medical care performed during 6 months. Method : It is a double blind randomized controlled trial. Principal criteria of assessment is Pain intensity three months after injection.

Condition or disease Intervention/treatment Phase
Tennis Elbow Drug: Botulinum Toxin A Injection Drug: Placebo injection Phase 3

Detailed Description:
  • Principal Objective : The first aim of the study is to value the effectiveness of botulinum toxin injection in the treatment of tennis elbow unrelieved by usual medical care performed during 6 months..
  • Secondary Objective : The second aim of this study is to document the tennis elbow history by a one year following after initial injection
  • Study design : It is a double blind randomized controlled trial. Principal criteria of assessment is Pain intensity three months after injection.
  • Inclusion criteria : tennis elbow during more than 6 months ; signature of consent
  • Exclusion criteria : Non inclusion criteria : less than 18 years old ; osteoarthritis elbow, referred cervical pain, fibromyalgia, pregnancy, myasthenia, polymyositis, SLA, anticoagulant treatment, aminosides ; diabetes, alcoholism
  • Study plan: randomized parallel groups
  • Number of subjects : 60

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 61 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Effectiveness of Botulinum Toxin A Injection for the Treatment of Lateral Epicondylitis Unrelieved by Usual Medical Cares : A Double Blind Randomized Controlled Trial Versus Placebo
Study Start Date : April 2007
Actual Primary Completion Date : June 2012
Actual Study Completion Date : June 2012

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: 1
Botulinum Toxin A Injection
Drug: Botulinum Toxin A Injection
Botulinum Toxin A Injection

Placebo Comparator: 2
Placebo injection
Drug: Placebo injection
Placebo Injection




Primary Outcome Measures :
  1. Principal criteria of assessment is pain intensity three months after injection. [ Time Frame: at 3 month ]

Secondary Outcome Measures :
  1. pain intensity [ Time Frame: to day 30, 90,180, 365 ]
  2. Number of painful days [ Time Frame: to day 30, 90,180, 365 ]
  3. Number of associated treatments. [ Time Frame: to day 30, 90,180, 365 ]
  4. Free pain grip strength [ Time Frame: to day 30, 90,180, 365 ]
  5. Rate of recidivism after initial relief [ Time Frame: to day 30, 90,180, 365 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Tennis elbow during more than 6 months
  • Signature of consent

Exclusion Criteria:

  • Less than 18 years old
  • Osteoarthritis elbow
  • Referred cervical pain
  • Fibromyalgia
  • Pregnancy
  • Myasthenia
  • Polymyositis
  • SLA
  • Anticoagulant treatment
  • Aminosides
  • Diabetes
  • Alcoholism
  • Previous botulinum toxin A injections

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00437762


Locations
Layout table for location information
France
Unité de médecine orthopédique- Hôpital Pellegrin RDC aile 2.
Bordeaux cedex, France, 330076
Sponsors and Collaborators
University Hospital, Bordeaux
Ipsen
Investigators
Layout table for investigator information
Principal Investigator: Mathieu DE SEZE, MD University Hospital, Bordeaux
Layout table for additonal information
Responsible Party: University Hospital, Bordeaux
ClinicalTrials.gov Identifier: NCT00437762    
Other Study ID Numbers: CHUBX 2005/08
First Posted: February 21, 2007    Key Record Dates
Last Update Posted: February 28, 2013
Last Verified: February 2013
Keywords provided by University Hospital, Bordeaux:
Lateral epicondylitis, tennis elbow, treatment
Additional relevant MeSH terms:
Layout table for MeSH terms
Tennis Elbow
Elbow Tendinopathy
Tendinopathy
Muscular Diseases
Musculoskeletal Diseases
Arm Injuries
Wounds and Injuries
Tendon Injuries
Botulinum Toxins
Botulinum Toxins, Type A
abobotulinumtoxinA
Acetylcholine Release Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Cholinergic Agents
Neurotransmitter Agents
Physiological Effects of Drugs
Neuromuscular Agents
Peripheral Nervous System Agents